Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Discover why former Real Housewives of Atlanta star Cynthia Bailey quit the weight loss drug Ozempic after giving it a try.

The report by GlobalData, a data and analytics company, showed that anti-obesity medications are the industry trend that will ...

Second, Amneal has received approval from the FDA for exenatide, which is the Company’s first generic injectable glucagon-like peptide-1 (GLP-1) agonist and reflects its innovation capabilities ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Popular weight management drugs like Ozempic only come in injectable form ... companies are working to create a pill version of a glucagon-like peptide 1 (GLP-1) receptor agonist, which would ...

Research has shown that these "glucagon-like peptide-1 (GLP-1 ... in August found that less than half those prescribed injectable weight loss drugs stay on them for six months, and less than ...

The company is still digging for efficacy signals among subpopulations in the CedLara trial, but has switched its attention to vurolenatide, an injectable glucagon-like peptide-2 (GLP-2 ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...